Leerink Positive on ViiV's (GSK) Acquisition of HIV Assets from Bristol-Myers Squibb (BMY)
Tweet Send to a Friend
Leerink affirms GlaxoSmithKline (NYSE: GSK) with a Market Perform rating and 48 price target following news that ViiV Healthcare would ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
